Novartis is a pharmaceutical company based in Switzerland that researches, develops and makes prescription medicines. Its products treat conditions in areas such as cancer, heart disease, immunology, neuroscience and eye care, and it also supplies generic drugs through its Sandoz business. Its customers are mainly hospitals, doctors, pharmacies and health systems in countries around the world, and it runs research and manufacturing sites internationally.
The shares are listed on the London Exchange in UK under the code 0K9E, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #1317 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
56/100
Mixed trend against its averages.
See the numbers →
Above 200-day average1.9%
From 52-week high-7.1%
MomentumFair
55/100
Typical recent returns for this exchange.
See the numbers →
3-month return-0.3%
6-month return4.3%
12-month, skipping last month10.2%
Stability (higher is calmer)Strong
77/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)26.4%
Worst drawdown, 1 year (smaller is calmer)-16.9%
LiquidityFair
51/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.87M USD
Zero-volume days0.0%
IncomeFair
54/100
Dividend is typical for this exchange.
See the numbers →
Dividend yield2.6%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 118.60 – 166.02Daily closes, split-adjusted
Signals
50-day average148.13
200-day average150.62
Golden/death cross (60d)Death, 10 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)3.17
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
146.9
Bullish
EMA 10
148.0
Bullish
SMA 20
144.9
Bullish
EMA 20
146.4
Bullish
SMA 50
148.1
Bullish
EMA 50
147.4
Bullish
SMA 100
150.7
Bullish
EMA 100
148.7
Bullish
SMA 200
150.6
Bullish
EMA 200
146.0
Bullish
Oscillators (daily)
RSI (14)
67.09
Neutral
MACD (12, 26)
1.15
Bullish
Momentum (12)
9.46
Bullish
Stochastic %K (14)
98.40
Bearish
Williams %R (14)
-1.60
Bearish
CCI (20)
192.1
Bearish
Pivot points (classic, last session)
S3
147.3
S2
148.7
S1
151.1
Pivot
152.5
R1
154.9
R2
156.2
R3
158.7
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
4.02 CHF
Yield on today's price
2.62%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
11 Mar 2026
4.0172
12 Mar 2025
3.2771
7 Mar 2024
3.1986
9 Mar 2023
2.2742
8 Mar 2022
2.1614
4 Mar 2021
2.0794
3 Mar 2020
2.0068
4 Mar 2019
1.8422
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in USD. Educational only, not financial advice.
